Autoimmune Disease Diagnostics Market Trends US$ 16 billion by 2026
Market Overview:
The ‘Autoimmune Disease Diagnostics Market– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,’ report provides analysis of the global Autoimmune Disease Diagnostics market for the period from 2016 to 2026, wherein 2018–2026 is the forecast period and 2018 is the base year. Data for 2017 has been included as historical information.
Free Download Sample Report Pages For Better understanding@https://www.acumenresearchandconsulting.com/request-sample/1177
The report covers all trends and technologies expected to play a major role in the growth of the global Autoimmune Disease Diagnostics market during the forecast period. It highlights drivers, restraints, and opportunities expected to influence the market from 2018 to 2026. The study provides a holistic perspective on the Autoimmune Disease Diagnostics market, in terms of revenue (in US$ Mn) and volume (in million units), across different regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The report highlights key trends affecting the Autoimmune Disease Diagnostics market at the global level. Prominent countries/sub-regions covered in the report include the U.S., Canada, Germany, France, the U.K., Italy, Russia, India, China, Japan, South Korea, South East Asia, GCC, South Africa, and Brazil.
utoimmune Disease Diagnostics Market by Product
Systemic
Rheumatoid arthritis diagnostics
Ankylosing spondylitis diagnostics
Systemic lupus erythematosus diagnostics
Others
- Localized
Global Autoimmune disease diagnostics Market, by Geography
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
Rest of Asia-Pacific
Latin America
Brazil
Chile
Rest of Latin America
Middle East and Africa (MEA)
South Africa
Saudi Arabia
Rest of MEA
This report analyzes and forecasts the market for Autoimmune Disease Diagnostics at the global and regional levels. The market has been forecast in terms of revenue (in US$ Mn) and volume (in million units) from 2018 to 2026. The study includes drivers and restraints of the global market. It also covers the anticipated impact of these drivers and restraints during the forecast period.
The report comprises detailed ecosystem analysis, which provides a comprehensive view of the global Autoimmune Disease Diagnostics market. Porter’s five forces model has also been included to help understand the competition landscape of the market. Additionally, current indicators of diverse macro-economic factors are contextualized under key market indicators.
Research Methodology
Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, internal and external proprietary databases, relevant patent and regulatory databases, national government documents, statistical databases, market reports, news articles, press releases, webcasts specific to companies operating in the market, national government documents, statistical databases, and Factiva.
Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews conducted for each market segment across geographies. ARC conducts primary interviews on an ongoing basis with market participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competition landscape, and market outlook. This help validates and strengthens secondary research findings. They also help develop the analysis team’s expertise and market understanding.
TABLE OF CONTENTS
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Autoimmune Disease Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Autoimmune Disease Diagnostics Market By Product
1.2.2.1. Global Autoimmune Disease Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Autoimmune Disease Diagnostics Market Revenue Share By Product in 2017
1.2.2.3. Systemic
1.2.2.4. Localized
1.2.2.5. Others
1.2.3. Autoimmune Disease Diagnostics Market by Geography
1.2.3.1. Global Autoimmune Disease Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Autoimmune Disease Diagnostics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Autoimmune Disease Diagnostics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Autoimmune Disease Diagnostics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Autoimmune Disease Diagnostics Major Manufacturers in 2017
CHAPTER 4. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY PRODUCT
4.1. Global Autoimmune Disease Diagnostics Revenue By Product
4.2. Systemic
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Localized
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY
5.1. North America Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Autoimmune Disease Diagnostics Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 6. EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY
6.1. Europe Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 7. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY
7.1. Asia-Pacific Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 8. LATIN AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY
8.1. Latin America Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 9. MIDDLE EAST AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY
9.1. Middle East Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 10. AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY
10.1. Africa Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. StraZeneca
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Inova Diagnostics Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Novartis AG
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Abbott Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Pfizer Inc.
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. F. Hoffmann-La Roche
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Bio-Rad Laboratories Inc.
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Hemagen Diagnostics Inc.
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Beckman Coulter Inc.
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Sanofi-aventis
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Others
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1177